91ºÚÁÏÍø Regulatory News
Who's Taking the Tech Route on Patient Care?
New 91ºÚÁÏÍø survey sheds light on telemedicine adoption and hurdles.
Advocacy in Action
Why Tackle Climate Change? ‘Our Health and the Planet Are at Stake’
91ºÚÁÏÍø speaks out in an effort to mitigate the negative effects on public health.
91ºÚÁÏÍø Fears New Rule Makes More Patients Vulnerable to Not Getting Needed Care
Federal regulation expands medical professionals' options to refuse care that conflicts with their moral or religious beliefs.
In Case You Missed It
91ºÚÁÏÍø offers tools, resources on fostering productive health care cost conversations
91ºÚÁÏÍø's new Cost of Care Conversations tools help physicians and patients understand the importance of talking about costs of health care and efficiently and effectively address cost issues in the clinical setting. Health care costs have been rising steadily in the United States and are a common cause of financial distress for patients. Acknowledging and discussing the costs of care with patients may impact care plans and eventually result in a stronger clinician-patient relationship and better patient outcomes.
The resources, which include evidence-based articles and training tools, were developed with grant support from the Robert Wood Johnson Foundation. A features eight articles and related multimedia content suggesting strategies for discussing the cost of care with patients during clinical encounters. The supplement includes designed to overcome barriers that may impede such conversations. The tools include free online health care cost estimator resources and a cost distress screening tool and conversation guide.
91ºÚÁÏÍø encouraged by rule requiring drug pricing transparency in TV ads
91ºÚÁÏÍø is encouraged by the final rule announced by the Trump Administration to require pharmaceutical manufacturers to disclose the cost of drugs in television advertisements. 91ºÚÁÏÍø believes that this is a promising step in improving transparency in prescription drug pricing. Prescription medications are only as effective as a patient's ability to access and adhere to treatment as prescribed.
91ºÚÁÏÍø outlined its support for increasing transparency in the pricing, cost, and comparative value of all pharmaceutical products in our 2016 policy paper, .
91ºÚÁÏÍø Advocate is copyrighted ©2019 by the American College of Physicians.